Evidence map›Paper›PMID 26757274›Full record

ArticleMenopause (New York, N.Y.)2016

Oral contraceptive use and fracture risk around the menopausal transition.

Delia Scholes, Andrea Z LaCroix, Rebecca A Hubbard, Laura E Ichikawa, Leslie Spangler, Belinda H Operskalski, Nancy Gell, Susan M Ott

Abstract read
In one paragraph

Article in Menopause (New York, N.Y.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Menstrual and reproductive factors and risk of vertebral fractures in Japanese women: the Japan Public Health Center-based prospective (JPHC) study.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Delia Scholes1Group Health Research Institute, Group Health Cooperative 2Department of Family and Preventive Medicine, University of California, San Diego, CA 3Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 4Center for Observational Research, Amgen Inc., Thousand Oaks, CA 5Department of Rehabilitation and Movement Science, University of Vermont, Burlington, VT 6Department of Medicine, University of Washington, Seattle, WA.
Andrea Z LaCroix
Rebecca A Hubbard
Laura E Ichikawa
Leslie Spangler
Belinda H Operskalski
Nancy Gell
Susan M Ott

Funding

Oral Contraceptive Use and Fractures Around the Menopausal TransitionR01AG030086 · NIA · KAISER FOUNDATION HEALTH PLAN OF WASHINGTON · PI SCHOLES, DELIA · 2008 to 2012
$2.6M
Health Care Improvement for Aging WomenT32AG027677 · NIA · KAISER FOUNDATION HEALTH PLAN OF WASHINGTON · PI LACROIX, ANDREA Z. · 2007 to 2016
$1.4M
NIA NIH HHS R01 AG030086NIA NIH HHS T-32 AG027677NIA NIH HHS T32 AG027677
6 · The paper itself

Abstract

objectiveThe effect of oral contraceptive (OC) use on risk of fracture remains unclear, and use during later reproductive life may be increasing. To determine the association between OC use during later reproductive life and risk of fracture across the menopausal transition, we conducted a population-based case-control study in a Pacific Northwest HMO, Group Health Cooperative.

methodsFor the January 2008 to March 2013 interval, 1,204 case women aged 45 to 59 years with incident fractures, and 2,275 control women were enrolled. Potential cases with fracture codes in automated data were adjudicated by electronic health record review. Potential control women without fracture codes were selected concurrently, sampling based on age. Participants received a structured study interview. Using logistic regression, associations between OC use and fracture risk were calculated as odds ratios (ORs) and 95% confidence intervals (CIs).

resultsParticipation was 69% for cases and 64% for controls. The study sample was 82% white; mean age was 54 years. The most common fracture site for cases was the wrist/forearm (32%). Adjusted fracture risk did not differ between cases versus controls for OC use in the 10 years before menopause (OR 0.90, 95% CI 0.74, 1.11); for OC use after age 38 (OR 0.94, 95% CI 0.78, 1.14); for duration of use, or for other OC exposures.

conclusionsThe current study does not show an association between fractures near the menopausal transition and OC use in the decade before menopause or after age 38. For women considering OC use at these times, fracture risk does not seem to be either reduced or-reassuringly-increased.

Indexed as

MenopauseCase-Control StudiesConfidence IntervalsContraceptives, Oral, HormonalElectronic Health RecordsFemaleFractures, BoneHumansLogistic ModelsMiddle AgedNorthwestern United StatesOdds RatioPremenopauseRisk FactorsContraceptives, Oral, Hormonal

Identifiers

PMID26757274
PMCPMC4731309

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.